Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Ahn, Suzie E ^a   Choi, Jin W ^a   Rengaraj, Deivendran ^a   Seo, Hee W ^a   Lim, Whasun ^a   Han, Jae Y ^a   Song, Gwonhwa ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN B; CATHEPSIN H; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CATHEPSIN X; DIPEPTIDYL PEPTIDASE I; EOSIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMATOXYLIN; MESSENGER RNA; CYSTEINE PROTEINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHICKEN; CONTROLLED STUDY; FEMALE; HEN; HISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIRD DISEASE; CARCINOMA; COMPARATIVE STUDY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OVARY; OVARY TUMOR; PATHOLOGY; TISSUE DISTRIBUTION;

ANIMALIA; GALLUS GALLUS;

ANIMALS; CARCINOMA; CATHEPSINS; CHICKENS; CYSTEINE PROTEASES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; OVARY; POULTRY DISEASES; TISSUE DISTRIBUTION;

EID: 77955752516     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-100     Document Type: Article

References (46)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002, 52(1):23-47. 10.3322/canjclin.52.1.23, 11814064.
2. Orsulic S. Ovarian Cancer. Mouse Models of Human Cancer 2004, 171-187. New Jersey: Whiley-Liss, Inc, Holland EC.
3. Murdoch WJ, Van Kirk EA, Alexander BM. DNA damages in ovarian surface epithelial cells of ovulatory hens. Exp Biol Med (Maywood) 2005, 230(6):429-433.
4. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. The biology of ovarian cancer. Semin Oncol 1998, 25(3):281-304.
5. Fathalla MF. Incessant ovulation--a factor in ovarian neoplasia?. Lancet 1971, 2(7716):163. 10.1016/S0140-6736(71)92335-X, 4104488.
6. Johnson KA. The Standard of Perfection: Thoughts about the Laying Hen Model of Ovarian Cancer. Cancer Prev Res (Phila Pa) 2009, 2(2):97-99.
7. Murdoch WJ, Van Kirk EA, Alexander BM. DNA damages in ovarian surface epithelial cells of ovulatory hens. Exp Biol Med 2005, 230(6):429-433.
8. Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE. CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 2007, 104(1):192-198. 10.1016/j.ygyno.2006.07.024, 16942793.
9. Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N, O'Briant K, Drescher C, Urban N. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst 2010, 102(1):26-38. 10.1093/jnci/djp438, 2802285, 20042715.
10. Turk D, Guncar G. Lysosomal cysteine proteases (cathepsins): promising drug targets. Acta Crystallogr D Biol Crystallogr 2003, 59(Pt 2):203-213. 10.1107/S0907444902021479, 12554931.
11. Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J 2001, 20(17):4629-4633. 10.1093/emboj/20.17.4629, 125585, 11532926.
12. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 1998, 95(23):13453-13458. 10.1073/pnas.95.23.13453, 24840, 9811821.
13. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999, 10(2):197-206. 10.1016/S1074-7613(00)80020-5, 10072072.
14. Obermajer N, Jevnikar Z, Doljak B, Kos J. Role of cysteine cathepsins in matrix degradation and cell signalling. Connect Tissue Res 2008, 49(3):193-196. 10.1080/03008200802143158, 18661341.
15. Gocheva V, Joyce JA. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 2007, 6(1):60-64.
16. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006, 127(4):679-695. 10.1016/j.cell.2006.11.001, 17110329.
17. Scorilas A, Fotiou S, Tsiambas E, Yotis J, Kotsiandri F, Sameni M, Sloane BF, Talieri M. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol Chem 2002, 383(7-8):1297-1303. 10.1515/BC.2002.146, 12437120.
18. Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A, Suzumori K. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol Oncol 2004, 92(3):881-886. 10.1016/j.ygyno.2003.11.017, 14984956.
19. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Edassery SL, Rotmensch J, Luborsky JL. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 2009, 19(4):531-539. 2759668, 19509547.
20. Rengaraj D, Kim DK, Zheng YH, Lee SI, Kim H, Han JY. Testis-specific novel transcripts in chicken: in situ localization and expression pattern profiling during sexual development. Biol Reprod 2008, 79(3):413-420. 10.1095/biolreprod.108.067959, 18448841.
21. Zhuge Y, Lagman JA, Ansenberger K, Mahon CJ, Daikoku T, Dey SK, Bahr JM, Hales DB. CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus. Gynecol Oncol 2009, 112(1):171-178. 10.1016/j.ygyno.2008.09.026, 2741324, 18973935.
22. Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, Bahr JM, Hales DB. E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol 2009, 113(3):362-369. 10.1016/j.ygyno.2009.02.011, 2838372, 19321195.
23. Hales DB, Zhuge Y, Lagman JA, Ansenberger K, Mahon C, Barua A, Luborsky JL, Bahr JM. Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocrine 2008, 33(3):235-244. 10.1007/s12020-008-9080-z, 18498063.
24. Urick ME, Johnson PA. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol Oncol 2006, 103(2):673-678. 10.1016/j.ygyno.2006.05.012, 16797680.
25. Giles JR, Shivaprasad HL, Johnson PA. Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol Oncol 2004, 95(3):530-533. 10.1016/j.ygyno.2004.07.061, 15581958.
26. Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, Grizzle WE. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 2001, 81(3):373-379. 10.1006/gyno.2001.6191, 11371125.
27. Giles JR, Olson LM, Johnson PA. Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med (Maywood) 2006, 231(11):1718-1725.
28. Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, Hales DB, Luborsky JL. Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol 2008, 109(1):115-121. 10.1016/j.ygyno.2007.12.030, 2387249, 18272210.
29. Hakim AA, Barry CP, Barnes HJ, Anderson KE, Petitte J, Whitaker R, Lancaster JM, Wenham RM, Carver DK, Turbov J, Berchuck A, Kopelovich L, Rodriguez GC. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res (Phila Pa) 2009, 2(2):114-121.
30. Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res 2010, 38(Database issue):D227-233. 10.1093/nar/gkp971, 2808883, 19892822.
31. Jedeszko C, Sloane BF. Cysteine cathepsins in human cancer. Biol Chem 2004, 385(11):1017-1027. 10.1515/BC.2004.132, 15576321.
32. Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006, 6(10):764-775. 10.1038/nrc1949, 16990854.
33. Lankelma JM, Voorend DM, Barwari T, Koetsveld J, Van der Spek AH, De Porto AP, Van Rooijen G, Van Noorden CJ. Cathepsin L, target in cancer treatment?. Life Sci 2010, 86(7-8):225-233. 10.1016/j.lfs.2009.11.016, 19958782.
34. Yan S, Sameni M, Sloane BF. Cathepsin B and human tumor progression. Biol Chem 1998, 379(2):113-123.
35. Lah TT, Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 1998, 379(2):125-130.
36. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003, 3(7):489-501. 10.1038/nrc1121, 12835669.
37. Szpaderska AM, Frankfater A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res 2001, 61(8):3493-3500.
38. Premzl A, Zavasnik-Bergant V, Turk V, Kos J. Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp Cell Res 2003, 283(2):206-214. 10.1016/S0014-4827(02)00055-1, 12581740.
39. Warwas M, Haczynska H, Gerber J, Nowak M. Cathepsin B-like activity as a serum tumour marker in ovarian carcinoma. Eur J Clin Chem Clin Biochem 1997, 35(4):301-304.
40. Kolwijck E, Massuger LF, Thomas CM, Span PN, Krasovec M, Kos J, Sweep FC. Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors. J Cancer Res Clin Oncol 2009, 2841751, 19915865.
41. Lah TT, Kokalj-Kunovar M, Kastelic L, Babnik J, Stolfa A, Rainer S, Turk V. Cystatins and stefins in ascites fluid from ovarian carcinoma. Cancer Lett 1992, 61(3):243-253. 10.1016/0304-3835(92)90295-7, 1739949.
42. Scorilas A, Fotiou S, Tsiambas E, Yotis J, Kotsiandri F, Sameni M, Sloane BF, Talieri M. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol Chem 2002, 383(7-8):1297-1303. 10.1515/BC.2002.146, 12437120.
43. Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y, Pan JH, Lu ML, Cheng XW, Iguchi A, Perrey S, Lee AM, Chapman HA, Libby P. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 2003, 92(5):493-500. 10.1161/01.RES.0000060485.20318.96, 12600886.
44. Burden RE, Gormley JA, Jaquin TJ, Small DM, Quinn DJ, Hegarty SM, Ward C, Walker B, Johnston JA, Olwill SA, Scott CJ. Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis. Clin Cancer Res 2009, 15(19):6042-6051. 10.1158/1078-0432.CCR-09-1262, 19789302.
45. Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006, 20(5):543-556. 10.1101/gad.1407406, 1410800, 16481467.
46. Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, Greenbaum DC, Hager JH, Bogyo M, Hanahan D. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004, 5(5):443-453. 10.1016/S1535-6108(04)00111-4, 15144952.